独立所有社区药房对免疫信息系统的利用情况:一项全国性调查
该研究于2022年秋季对全国社区药师协会的药师、药房业主和药房技术人员会员开展横断面在线调查,分析202份完整应答。结果显示91.6%的受访药房已注册免疫信息系统(IIS),约三分之二在免疫前经常或总是通过IIS检索免疫记录,流感疫苗和非新冠非流感疫苗接种记录的平均提交率分别为81.2%和83.5%,但记录检索率欠佳。
要点
- 91.6%的受访独立社区药房已注册免疫信息系统(IIS)。
- 约三分之二受访药房在免疫前经常或总是通过IIS检索免疫记录。
- 流感疫苗和非新冠非流感疫苗接种记录平均提交率分别为81.2%和83.5%。
核心结论
- 受访药房的IIS注册率和记录报告率均较高,但记录检索率欠佳,未来工作应聚焦于解决提供免疫服务的药房内检索率欠佳的问题。
研究设计与样本
- 2022年秋季对全国社区药师协会的药师、药房业主和药房技术人员会员开展横断面在线调查,分析202份完整应答,估计误差范围为7%。
主要发现
- 受访者中53.2%为女性,约87%为白人,69.8%为管理者,86.1%在独立社区药房执业。
- 91.6%的受访药房已注册IIS。
- 约三分之二受访药房在免疫前经常或总是利用IIS检索免疫记录。
- 平均81.2%的流感疫苗接种记录和83.5%的非新冠非流感疫苗接种记录已提交。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVE: Immunization information systems (IIS) consolidate provider-submitted immunization information. We reassessed independently owned community pharmacies' IIS enrollment, verification of immunizations needs via IIS records retrieval, and immunization records reporting to IISs following post-pandemic shifts in community pharmacy operations. METHODS: A cross-sectional online survey of National Community Pharmacists Association pharmacist, pharmacy owner, and pharmacy technician members was conducted in Fall 2022. RESULTS: 202 complete responses were analyzed. Margin of error was an estimated 7 %. Respondents were: 53.2 % female, ∼87 % White, 69.8 % managers, and 86.1 % practicing in standalone community pharmacies. Almost all (91.6 %) were enrolled in IIS. About two-thirds frequently or always utilized IIS to retrieve immunization records prior to immunization. On average, 81.2 % of influenza and 83.5 % of non-COVID/non-influenza vaccination records were submitted. CONCLUSIONS: Enrollment rates are high among studied pharmacies, as are records reporting rates. However, records retrieval rates are suboptimal. Future work should focus on addressing suboptimal retrieval rates within immunization-providing pharmacies.
引用
- Meininger C, Ezeala O, McCormick N, et al. Utilization of Immunization Information Systems (IIS) among independently owned community pharmacies: A national survey. Vaccine. 2023. PMID: 38103965. doi:10.1016/j.vaccine.2023.12.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。